No connection

Search Results

Analysis Neutral

Is This Biotech Stock Your Best Shot at Building a Millionaire-Making Position?

Apr 07, 2026 09:03 UTC

Key PointsCRISPR Therapeutics is the second largest holding in Cathie Wood's Ark Innovation ETF..

  • April 07, 2026 — 05:03 am EDT Written byCory RenauerforThe Motley Fool-> CRISPR Therapeutics is the second largest holding in Cathie Wood's Ark Innovation ETF
  • Incoming clinical trial data could send the stock soaring this year
  • Investors looking for stocks that can turn a modest portfolio into a multimillion-dollar nest egg often find what they're looking for inthe biotech industry

April 07, 2026 — 05:03 am EDT Written byCory RenauerforThe Motley Fool-> CRISPR Therapeutics is the second largest holding in Cathie Wood's Ark Innovation ETF. Incoming clinical trial data could send the stock soaring this year. Investors looking for stocks that can turn a modest portfolio into a multimillion-dollar nest egg often find what they're looking for inthe biotech industry. For several years,CRISPR Therapeutics(NASDAQ: CRSP)has been attracting investment from Cathie Wood'sArk Innovation ETF. At the moment, it's the fund's second largest holding, at 6.6% of the overall portfolio. You

Sign up free to read the full analysis

Create a free account to unlock full AI-curated market articles, personalized alerts, and more.

Create Free Account Already have an account? Sign In
Share this article

Stay Ahead of the Markets

Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.

Get Started Free View Plans
Features Terminal AI Assistant Analysis Market News Pricing
Start Trading with AI Already have an account? Sign In
Home
Terminal
AI
Markets
Profile